Recent News

November 22, 2022

scPharmaceuticals Announces Pricing of $50 Million Public Offering

Read More
November 21, 2022

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock

Read More
November 09, 2022

scPharmaceuticals Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update

Read More
November 02, 2022

scPharmaceuticals to Participate in the Jefferies London Healthcare Conference

Read More